Home › NDC Lookup › Ingredients › Dextromethorphan Hydrobromide Guaifenesi... › 70000-0722-01
Leader Mucus Relief DM dextromethorphan hydrobromide, guaifenesin 30 mg; 600 mg Tablet, Extended Release, 20-count — NDC 70000-0722-01 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Leader Mucus Relief DM dextromethorphan hydrobromide, guaifenesin 30 mg; 600 mg Tablet, Extended Release, 20-count — NDC 70000-0722-1 (Billing 70000-0722-01)

by Cardinal Health 110, LLC. dba Leader · 1 BOTTLE in 1 CARTON / 20 TABLET, EXTENDED RELEASE in 1 BOTTLE

This is a package of 20 tablets of Leader Mucus Relief DM dextromethorphan hydrobromide, guaifenesin 30 mg; 600 mg Tablet, Extended Release from Cardinal Health 110, LLC. dba Leader, marketed since Mar 2025 and currently FDA-listed; retail pharmacies pay about $0.3560 per tablet (NADAC). It is this product's only package size.

NDC 70000-0722-01
🏷️ FDA NDC (as labeled) 70000-0722-1 billing pads the package segment with a zero
OTC Generic On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Oct 1, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 70000-0722-1
Product NDC 70000-0722
11-digit billing NDC 70000072201
NCPDP billing unit EA — each (per item)
RxCUI 1298324
UNII 9D2RTI9KYH, 495W7451VQ
Application # ANDA207602
SPL Set ID 7c54d128-9da7-49d7-bda4-9d4f7b8bc652
Established class (EPC) Expectorant
Physiologic effect Decreased Respiratory Secretion Viscosity; Increased Respiratory Secretions
DEA schedule Non-controlled
Marketing category ANDA
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2025-03-08
Route ORAL
Dosage form TABLET, EXTENDED RELEASE
Substance DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GCN Seq No 012074
GCN 53550
HICL code 000223
Ingredient (HICL) Guaifenesin/Dextromethorphan
HIC1 code B
Therapeutic class — broad (HIC1) Respiratory System
HIC2 code B3
Therapeutic class — intermediate (HIC2) Drugs Affecting Primarily The Trachea And Bronchi
HIC3 code B3T
Therapeutic class — specific (HIC3) Non-Opioid Antitussive And Expectorant Combination
AHFS code 48:08.00.00
AHFS class Antitussives
FDB label name MUCUS RLF DM ER 600-30 MG TAB
FDB brand name Mucus Relief Dm Er
Legend status O — Over-the-counter (OTC) drug or device
Quick answers
  • GSN (GCN sequence number): 012074
  • GCN: 53550
  • HICL (First Databank): 000223
  • AHFS class code: 48:08.00.00
  • RxCUI (RxNorm): 1298324
Why two NDCs? The FDA registers this code as 70000-0722-1 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 70000-0722-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Uncompetitive N-methyl-D-aspartate Receptor Antagonist class.

Pharmacologic class Uncompetitive N-methyl-D-aspartate Receptor Antagonist, Sigma-1 Agonist
Drug family (ATC) Other antidepressants, Opium alkaloids and derivatives
How it works Uncompetitive NMDA Receptor Antagonists, Sigma-1 Receptor Agonists
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

Label name MUCUS RLF DM ER 600-30 MG TAB Ingredient Guaifenesin/Dextromethorphan
📖 What it is MedlinePlus · NLM

Dextromethorphan is used to temporarily relieve cough caused by the common cold, the flu, or other conditions. Dextromethorphan will relieve a cough but will not treat the cause of the cough or speed recovery. Dextromethorphan is in a class of medications called antitussives. It works by decreasing activity in the part of the brain that causes coughing.

Read the full MedlinePlus article ↗
📗 Our plain-language guide HelloPharmacist
  • It helps loosen mucus and makes coughs more productive. It also temporarily eases cough from minor throat and bronchial irritation, like with a cold or inhaled irritants.
  • Swallow them whole with a full glass of water. Don’t crush, chew or break them. You can take them with or without food, about every 12 hours as your label directs.
  • How do I take the extended-release tablets?
  • The extended-release tablets are not for children under 12. Some liquid products are made for children, so check that product’s label and ask me if you’re unsure.
📖 Read our full Dextromethorphan / Guaifenesin guide →

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eaPer package
Retail pharmacies payNADAC · weekly $0.356 $7.12 / 20 tablets
Medicaid paysCMS SDUD · 12 mo $0.7082 $14.16 / 20 tablets
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per ea) — tap or hover for the price & month
Dec 2025 Mar 2026 Jun 2026 Sep 2026 $0.394 $0.348
▼ Down 6% over the last 10 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
70000-0722-01 You're viewing this Main listing 1 BOTTLE in 1 CARTON / 20 TABLET, EXTENDED RELEASE in 1 BOTTLE 2025-03-08 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Mucus Relief DM Extended Release Caplets 600 mg/1; 30 mg 00536-1161-34 Rugby 20 tablets $0.356 — Availability likely —
Rugby Mucus Relief DM ER 30 mg/1; 600 mg 00536-1446-34 Rugby 20 tablets $0.356 — Availability likely —
Good Neighbor Pharmacy Mucus Dm 30 mg/1; 600 mg 46122-0817-61 Amerisource 20 tablets $0.356 — Availability likely —
Leader Mucus Relief DM 30 mg/1; 600 mgthis 70000-0722-01 Cardinal 20 tablets $0.356 — Availability likely —
Mucus Relief DM 600 mg/1; 30 mg 70677-1050-01 Strategic 1 tablet $0.356 — Availability likely —
Mucus Relief DM 600 mg/1; 30 mg 70000-0491-01 CARDINAL 20 tablets $0.359 — Discontinued +1%
Mucinex DM 600 mg/1; 30 mg 63824-0056-01 Reckitt 20 tablets $0.608 — Discontinued +71%
Good Sense Mucus DM 30 mg/1; 600 mg 00113-2219-01 L. 20 tablets — — FDA listed —
Mucus Relief DM 600 mg/1; 30 mg 00363-0474-01 WALGREEN 10 tablets — — FDA listed —
Mucus Relief DM Extended Release Caplets 600 mg/1; 30 mg 00363-0733-20 Walgreens 20 tablets — — FDA listed —
Mucus Relief DM 30 mg/1; 600 mg 00363-3219-01 Walgreen 20 tablets — — FDA listed —
up and up mucus relief dm 30 mg/1; 600 mg 11673-0716-01 Target 20 tablets — — FDA listed —
Mucus Relief DM 600 mg/1; 30 mg 11822-0733-02 Rite 20 tablets — — FDA listed —
mucus relief DM 30 mg/1; 600 mg 11822-2219-00 Rite 20 tablets — — FDA listed —
Mucus Relief DM Extended Release Caplets 600 mg/1; 30 mg 17856-1162-01 ATLANTIC 1 tablet — — FDA listed —
Mucus Relief Dm 600 mg/1; 30 mg 21130-0997-67 Better 10 tablets — — FDA listed —
Guaifenesin and Dextromethorphan HBr 600 mg/1; 30 mg 30142-0276-20 KROGER 10 tablets — — FDA listed —
Guaifenesin And Dextromethorphan Hbr 600 mg/1; 30 mg 30142-0948-20 Kroger 20 tablets — — FDA listed —
Topcare Mucus DM 30 mg/1; 600 mg 36800-0219-01 Topco 20 tablets — — FDA listed —
Mucus Relief DM 600 mg/1; 30 mg 37808-0733-40 H 40 tablets — — FDA listed —
equaline mucus dm 30 mg/1; 600 mg 41163-0599-01 United 20 tablets — — FDA listed —
mucus relief dm 30 mg/1; 600 mg 41250-0436-01 Meijer 20 tablets — — FDA listed —
Guaifenesin and Dextromethorphan HBr 600 mg/1; 30 mg 41415-0998-20 PUBLIX 20 tablets — — FDA listed —
Mucus Dm 30 mg/1; 600 mg 42507-0222-20 HyVee 20 tablets — — FDA listed —
Guaifenesin and Dextromethorphan HBR 600 mg/1; 30 mg 43598-0114-01 Dr. 20 tablets — — FDA listed —
Guaifenesin and Dextromethorphan HBR 600 mg/1; 30 mg 43598-0231-01 Dr. 20 tablets — — FDA listed —
Mucus Relief DM 600 mg/1; 30 mg 49035-0960-12 Wal-Mart 40 tablets — — FDA listed —
Mucinex Dm 600 mg/1; 30 mg 50090-1077-00 A-S 20 tablets — — FDA listed —
Mucinex DM 600 mg/1; 30 mg 50090-1078-00 A-S 20 tablets — — FDA listed —
Guaifenesin and Dextromethorphan HBR 600 mg/1; 30 mg 51316-0009-01 CVS 20 tablets — — FDA listed —
Cough And Congestion Extended Release 600 mg/1; 30 mg 51316-0065-67 CVS 10 tablets — — FDA listed —
Mucus Relief Dm 30 mg/1; 600 mg 51316-0858-78 CVS 100 tablets — — FDA listed —
Guaifenesin and Dextromethorphan HBr 600 mg/1; 30 mg 51660-0301-21 OHM 20 tablets — — FDA listed —
Mucus Relief DM 600 mg/1; 30 mg 55910-0733-06 Dolgencorp, 6 tablets — — FDA listed —
DG health mucus dm 30 mg/1; 600 mg 55910-0746-01 Dolgencorp 20 tablets — — FDA listed —
Guaifenesin and Dextromethorphan HBr 600 mg/1; 30 mg 58602-0714-05 Aurohealth 14 tablets — — FDA listed —
Guaifenesin and Dextromethorphan HBr 600 mg/1; 30 mg 58602-0824-08 Aurohealth 10 tablets — — FDA listed —
Guaifenesin and Dextromethorphan HBr 600 mg/1; 30 mg 58602-0871-83 Aurohealth 10 tablets — — FDA listed —
Mucus Relief DM 600 mg/1; 30 mg 59726-0733-06 P 6 tablets — — FDA listed —
Mucus Relief DM 600 mg/1; 30 mg 60000-0058-67 Ahold 20 tablets — — FDA listed —
Guaifenesin and Dextromethorphan HBr 600 mg/1; 30 mg 63304-0106-21 SUN 20 tablets — — FDA listed —
Mucus Relief DM 600 mg/1; 30 mg 63941-0733-20 Best 20 tablets — — FDA listed —
Guaifenesin and Dextromethorphan HBr 600 mg/1; 30 mg 65162-0038-03 Amneal 30 tablets — — FDA listed —
Mucinex DM, TRAVEL BASIX 600 mg/1; 30 mg 66715-6424-01 Lil' 2 tablets — — FDA listed —
Mucinex DM, CVP HEALTH 600 mg/1; 30 mg 66715-6524-01 Lil' 2 tablets — — FDA listed —
Mucinex DM 600 mg/1; 30 mg 66715-9724-01 Lil' 2 tablets — — FDA listed —
Mucus Relief DM Expectorant and Cough Suppressant 600 mg/1; 30 mg 67091-0314-20 Winco 10 tablets — — FDA listed —
Mucus Relief DM 600 mg/1; 30 mg 67091-0344-20 WinCo 20 tablets — — FDA listed —
Mucinex DM 30 mg/1; 600 mg 67751-0171-01 Navajo 2 tablets — — FDA listed —
Mucus DM Extended Release 600 mg/1; 30 mg 69842-0057-11 CVS 10 tablets — — FDA listed —
Mucus Relief DM 600 mg/1; 30 mg 69842-0933-20 CVS 20 tablets — — Discontinued —
mucus dm extended release 30 mg/1; 600 mg 69842-0963-01 CVS 20 tablets — — FDA listed —
Mucus Relief Dm 600 mg/1; 30 mg 72036-0012-20 Harris 10 tablets — — FDA listed —
basic care mucus dm 30 mg/1; 600 mg 72288-0219-49 Amazon.com 40 tablets — — FDA listed —
Amazon Basic Care Mucus Dm 600 mg/1; 30 mg 72288-0220-08 Amazon.com 10 tablets — — FDA listed —
Mucus Relief DM 600 mg/1; 30 mg 72476-0733-20 Care 20 tablets — — FDA listed —
equate mucus relief dm 30 mg/1; 600 mg 79903-0065-01 WALMART 20 tablets — — FDA listed —
Mucinex DM 600 mg/1; 30 mg 85237-1650-01 Select 2 tablets — — FDA listed —
Guaifenesin and Dextromethorphan HBr 600 mg/1; 30 mg 85766-0150-14 Sportpharm 14 tablets — — FDA listed —
Good Sense Mucus DM 30 mg/1; 600 mg 85766-0172-20 Sportpharm 20 tablets — — FDA listed —
Mucinex DM 600 mg/1; 30 mg 85766-0176-20 Sportpharm 20 tablets — — FDA listed —
About this product: this is a generic version of the medicine. FDA equivalence ratings are shown when available, and other versions are listed above, least expensive first.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2025
On the market since
Mar 2025
📍
2026
Currently FDA-listed
1 year listed
🔓
·
Generic on the market
this product is a generic
✅This is a generic drug

This product is an FDA-approved generic. Other versions of the same drug are listed under Therapeutic equivalents, least expensive first.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

What it looks like

Color Yellow
ShapeOval
ImprintL219;600
Size16 mm
ScoringNot scored
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII K6MOM3T5YL
    A synthetic polymer made from acrylic acid, crosslinked for stability. Used as a thickener and gelling agent to give medicines like creams and gels their texture, and as a binder to hold tablet ingredients together.
  • UNII D9C330MD8B
    Copovidone is a synthetic polymer made by combining two types of plastic-like molecules. It acts as a binder and film-former to help hold tablet ingredients together and improve how the medicine dissolves in your body.
  • UNII CQ3XH3DET6
    D&C Yellow No. 10 Aluminum Lake is a yellow colorant made by combining a dye with aluminum salts. It's used in medicines to add color for product identification and visual appeal.
  • UNII 3NXW29V3WO
    Hypromellose is a plant-based thickener made from cellulose. It's used in medicines as a binder to hold ingredients together, a coating for tablets, and a thickener for liquids.
  • UNII NBZ3QY004S
    Magnesium hydroxide is a mineral compound that acts as a buffer and pH adjuster in medications. It helps neutralize stomach acid and keeps the medicine at the right acidity level for stability and absorption.
  • UNII 70097M6I30
    Magnesium stearate is a salt made from magnesium and stearic acid, a fatty substance. It's used in tablets and capsules as a lubricant and glidant to help ingredients flow smoothly during manufacturing and prevent sticking.
  • UNII OP1R32D61U
    Microcrystalline cellulose is a purified form of cellulose, a natural fiber from plant sources. It acts as a binder and filler in tablets and capsules, helping hold ingredients together and give the medicine its shape and size.
  • UNII ETJ7Z6XBU4
    Silicon dioxide is a naturally occurring mineral used as a glidant and anti-caking agent. It helps powder ingredients flow smoothly and prevents clumping during manufacturing and storage.

8 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statescarbomer homopolymer type B, copovidone, D&C yellow #10 aluminum lake, hypromellose, magnesium hydroxide, magnesium stearate, microcrystalline cellulose, silicon dioxide

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerCardinal Health 110, LLC. dba Leader
Application holderPERRIGO R AND D CO
FDA applicationANDA207602 (ANDA)
Labeler code70000
First marketedMar 2025
Product typeHuman Otc Drug
Portfolio163 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Do Not Use 📄 Ask a Doctor Before Use If 📄 When Using This Product 📄 Stop Use and Ask a Doctor If 🤰 If Pregnant or Breast-Feeding 📄 Keep Out of Reach of Children 📄 Other Information 📄 Questions or Comments 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 61 words ▾

Uses • helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive • temporarily relieves: • cough due to minor throat and bronchial irritation as may occur with the common cold or inhaled irritants • the intensity of coughing • the impulse to cough to help you get to sleep

⏱️ Dosage and Administration 65 words ▾

Directions • do not crush, chew, or break extended-release tablet • take with a full glass of water • this product can be administered without regard for timing of meals • adults and children 12 years and older: 1 or 2 extended-release tablets every 12 hours; not more than 4 extended-release tablets in 24 hours • children under 12 years of age: do not use

⚠️ Warnings 171 words ▾

Warnings Do not use • for children under 12 years of age • if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric or emotional conditions, or Parkinson’s disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product. Ask a doctor before use if you have • persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema • cough accompanied by too much phlegm (mucus) When using this product • do not use more than directed Stop use and ask a doctor if • cough lasts more than 7 days, comes back, or occurs with fever, rash, or persistent headache.

These could be signs of a serious illness. If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away. (1-800-222-1222)

🧪 Active Ingredient 13 words ▾

Active ingredients (in each extended-release tablet) Dextromethorphan HBr 30 mg Guaifenesin 600 mg

🧪 Inactive Ingredients 21 words ▾

Inactive ingredients carbomer homopolymer type B, copovidone, D&C yellow #10 aluminum lake, hypromellose, magnesium hydroxide, magnesium stearate, microcrystalline cellulose, silicon dioxide

🎯 Purpose 4 words ▾

Purposes Cough suppressant Expectorant

📄 Do Not Use 64 words ▾

Do not use • for children under 12 years of age • if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric or emotional conditions, or Parkinson’s disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.

📄 Ask a Doctor Before Use If 31 words ▾

Ask a doctor before use if you have • persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema • cough accompanied by too much phlegm (mucus)

📄 When Using This Product 11 words ▾

When using this product • do not use more than directed

📄 Stop Use and Ask a Doctor If 32 words ▾

Stop use and ask a doctor if • cough lasts more than 7 days, comes back, or occurs with fever, rash, or persistent headache. These could be signs of a serious illness.

🤰 If Pregnant or Breast-Feeding 10 words ▾

If pregnant or breast-feeding, ask a health professional before use.

📄 Keep Out of Reach of Children 22 words ▾

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. (1-800-222-1222)

📄 Other Information 14 words ▾

Other information • each tablet contains: magnesium 15 mg • store between 20-25°C (68-77°F)

📄 Questions or Comments 4 words ▾

Questions or comments? 1-800-719-9260

📄 Package Label / Principal Display Panel 52 words ▾

Package/Label Principal Display Panel LEADER ™ Mucus Relief DM Dextromethorphan Hydrobromide, 30 mg Guaifenesin, 600 mg Extended-Release Tablets Cough Suppressant | Expectorant RELIEVES COUGH & CHEST CONGESTION 12-Hour Relief Controls Cough Thins and Loosens Mucus Actual Size COMPARE TO MUCINEX ® DM active ingredients 100% Money Back Guarantee 20 EXTENDED-RELEASE TABLETS mucus-relief-dm

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for this package alone, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q3 2025 – Q4 2025 · 2 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
65
Units reimbursed last 4 qtrs
1.7K
Gross reimbursed last 4 qtrs
$1.2K
Avg / prescription
$18.11
Avg / unit
$0.7082
Latest quarter Q4 2025
65Rx
Medicaid pays / ea
$0.7082
gross reimbursed
vs
NADAC / ea
$0.3560
acquisition cost
=
Spread
+$0.3522
+99% vs cost
What Medicaid paid per ea (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
100% MCO
Fee-for-service · 0 Rx Managed care · 65 Rx
State Medicaid map
Alaska: no data reported AK Maine: no data reported ME Washington: no data reported WA Idaho: no data reported ID Montana: no data reported MT North Dakota: no data reported ND Minnesota: no data reported MN Wisconsin: no data reported WI Michigan: no data reported MI New York: no data reported NY Vermont: no data reported VT New Hampshire: no data reported NH Oregon: no data reported OR Nevada: no data reported NV Wyoming: no data reported WY South Dakota: no data reported SD Iowa: no data reported IA Illinois: no data reported IL Indiana: no data reported IN Ohio: 314 units · 2.7 per 100k residents OH Pennsylvania: 768 units · 5.9 per 100k residents PA New Jersey: no data reported NJ Massachusetts: no data reported MA California: no data reported CA Utah: no data reported UT Colorado: no data reported CO Nebraska: no data reported NE Missouri: no data reported MO Kentucky: 580 units · 12.8 per 100k residents KY West Virginia: no data reported WV Virginia: no data reported VA Maryland: no data reported MD Connecticut: no data reported CT Rhode Island: no data reported RI Arizona: no data reported AZ New Mexico: no data reported NM Kansas: no data reported KS Arkansas: no data reported AR Tennessee: no data reported TN North Carolina: no data reported NC South Carolina: no data reported SC Delaware: no data reported DE Oklahoma: no data reported OK Louisiana: no data reported LA Mississippi: no data reported MS Alabama: no data reported AL Georgia: no data reported GA D.C.: no data reported DC Hawaii: no data reported HI Texas: no data reported TX Florida: no data reported FL
Units reimbursed · per 100k residents
2.712.8
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 Kentucky 12.8 /100k
2 Pennsylvania 5.9 /100k
3 Ohio 2.7 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Dextromethorphan hydrobromide, guaifenesin — the ingredient across all brands.

Top reported reactions

Dyspnoea1,849
Fatigue1,534
Nausea1,484
Diarrhoea1,463
Cough1,415
Pneumonia1,327
Headache1,294

Reporter sex

23,557 reports
Male · 35%
Female · 65%
Unknown · 0%

Serious outcomes

Death1,442
Life-threatening384
Disabling361
Reports over time (by year) — tap or hover for the count & year
2025 2026 1,817 890
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.
← 70000-0721-01 · Cardinal 70000-0723-01 · Cardinal →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.